Cargando…

Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors

BACKGROUND: High cyclooxygenase (COX)-2 expression in ovarian tumors has been associated with poor prognosis, but the role of COX-1 expression and its relation to survival is less clear. Here, we evaluated COX expression and associations with survival outcomes between type I (clear cell, mucinous, l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beeghly-Fadiel, Alicia, Wilson, Andrew J., Keene, Spencer, El Ramahi, Meral, Xu, Shu, Marnett, Lawrence J., Fadare, Oluwole, Crispens, Marta A., Khabele, Dineo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828488/ https://www.ncbi.nlm.nih.gov/pubmed/29482584 http://dx.doi.org/10.1186/s13048-018-0389-9

Ejemplares similares

CCNE1 and BRD4 co-amplification in high-grade serous ovarian cancer is associated with poor clinical outcomes
por: Petersen, Shariska, et al.
Publicado: (2020)

Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: analysis of laboratory measures from electronic medical records
por: Cozzi, Gabriella D., et al.
Publicado: (2016)

Blood type, ABO genetic variants, and ovarian cancer survival
por: Cozzi, Gabriella D., et al.
Publicado: (2017)

Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer
por: Wilson, Andrew J., et al.
Publicado: (2015)

Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis
por: Hufnagel, Demetra H., et al.
Publicado: (2020)

Platelets, Thrombocytosis, and Ovarian Cancer Prognosis: Surveying the Landscape of the Literature
por: Hufnagel, Demetra H., et al.
Publicado: (2020)

A Case of Extrauterine Endometrial Stromal Sarcoma in the Colon Diagnosed Three Decades after Hysterectomy for Benign Disease
por: Ayuso, Andres, et al.
Publicado: (2013)

Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer
por: Wilson, Andrew J., et al.
Publicado: (2021)

Adrenal Gland Metastasis Is an Unusual Manifestation of Endometrial Cancer
por: Zaidi, Syeda Sadia, et al.
Publicado: (2013)

Chemokine Network and Overall Survival in TP53 Wild-Type and Mutant Ovarian Cancer
por: Ignacio, Rosa Mistica C., et al.
Publicado: (2018)

The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer
por: Khabele, Dineo
Publicado: (2014)

Incidental placenta increta at the time of prophylactic hysterectomy for Lynch syndrome: Insights into individualized decision-making and surgical timing
por: Nielsen, Tara A., et al.
Publicado: (2015)

Thailandepsins are new small molecule class I HDAC inhibitors with potent cytotoxic activity in ovarian cancer cells: a preclinical study of epigenetic ovarian cancer therapy
por: Wilson, Andrew J, et al.
Publicado: (2012)

Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy
por: Gupta, Vijayalaxmi, et al.
Publicado: (2018)

Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer
por: Hoover, Alyssa A., et al.
Publicado: (2020)

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer
por: Jewell, Andrea, et al.
Publicado: (2018)

Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer
por: Wilson, Andrew J., et al.
Publicado: (2015)

Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer
por: Wilson, Andrew J., et al.
Publicado: (2015)

Obesity-Induced Peritoneal Dissemination of Ovarian Cancer and Dominant Recruitment of Macrophages in Ascites
por: Ignacio, Rosa Mistica C., et al.
Publicado: (2018)

Pharmacological ascorbate induces ‘BRCAness’ and enhances the effects of Poly(ADP-Ribose) polymerase inhibitors against BRCA1/2 wild-type ovarian cancer
por: Ma, Yan, et al.
Publicado: (2020)

Structural and Chemical Biology of the Interaction of Cyclooxygenase with Substrates and Non-Steroidal Anti-Inflammatory Drugs
por: Rouzer, Carol A., et al.
Publicado: (2020)

Discovery of Furanone-Based Radiopharmaceuticals for Diagnostic Targeting of COX-1 in Ovarian Cancer
por: Uddin, Md. Jashim, et al.
Publicado: (2019)

High-Fat Diet-Induced Obese Effects of Adipocyte-Specific CXCR2 Conditional Knockout in the Peritoneal Tumor Microenvironment of Ovarian Cancer
por: Choe, Deokyeong, et al.
Publicado: (2021)

Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways
por: Rouzer, Carol A., et al.
Publicado: (2011)

Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer
por: Glass, Evan B., et al.
Publicado: (2022)

Anthropometric measures and epithelial ovarian cancer risk among Chinese women: results from the Shanghai Women's Health Study
por: Ma, X, et al.
Publicado: (2013)

Disparities in ovarian cancer survival at the only NCI-designated cancer center in Kansas
por: Petersen, Shariska, et al.
Publicado: (2020)

[(123)I]-Celecoxib Analogues as SPECT Tracers of Cyclooxygenase-2 in Inflammation
por: Uddin, Md. Jashim, et al.
Publicado: (2010)

Augmented Serum Amyloid A1/2 Mediated by TNF-induced NF-κB in Human Serous Ovarian Epithelial Tumors
por: Choi, Hyeongjwa, et al.
Publicado: (2017)

Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model
por: Wilson, Andrew J, et al.
Publicado: (2013)

Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers
por: Fadare, Oluwole, et al.
Publicado: (2008)

Substrate-Selective Inhibition of Cyclooxygenase-2: Development and Evaluation of Achiral Profen Probes
por: Windsor, Matthew A., et al.
Publicado: (2012)

Preferential Effect of Akt2-Dependent Signaling on the Cellular Viability of Ovarian Cancer Cells in Response to EGF
por: Khabele, Dineo, et al.
Publicado: (2014)

CXCR2 is a negative regulator of p21 in p53-dependent and independent manner via Akt-mediated Mdm2 in ovarian cancer
por: Ignacio, Rosa Mistica C., et al.
Publicado: (2018)

Cyclooxygenase-2 inhibition reduces stress-induced affective pathology
por: Gamble-George, Joyonna Carrie, et al.
Publicado: (2016)

Sulindac Derivatives That Activate the Peroxisome Proliferator-activated Receptor γ but Lack Cyclooxygenase Inhibition
por: Felts, Andrew S., et al.
Publicado: (2008)

Cyclooxygenase-1-Selective Inhibitors Based on the (E)-2′-Des-methyl-sulindac Sulfide Scaffold
por: Liedtke, Andy J., et al.
Publicado: (2012)

Modeling the Impact of Delaying Bariatric Surgery due to COVID-19: a Decision Analysis
por: Shipe, Maren E., et al.
Publicado: (2020)

Aspirin Blocks EGF-stimulated Cell Viability in a COX-1 Dependent Manner in Ovarian Cancer Cells
por: Cho, May, et al.
Publicado: (2013)

Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis
por: Li, Jie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hgc9jd1aqcbc0mcu9ubkhg94m6